Company Financials

Travere Therapeutics Inc. Financials

United States dollar

business Travere Therapeutics Inc. Company Profile

Main Stock Listing

NASDAQ: TVTX

Market Capitalization $1.33 Billion as of July 1, 2025

Market Cap History

Valuations Metrics as of Jul. 5, 2025

Trailing PE -3.68
Forward PE -12.30
Price to Sales TTM $4.87
Price to Book MRQ $40.57
Enterprise to Revenue 5.09
Enterprise to EBITDA -7.80

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-03-31
Profit Margin -82.88%
Operating Margin -52.21%
Return on Assets TTM -23.21%
Return on Equity TTM -422.66%

Income Statement

Revenue TTM $273,532,992
Revenue per Share TTM $3.35
Quarterly Revenue Growth 97.50%
Gross Profit TTM $47,649,000
EBITDA $-178,608,000
Net Income to Common TTM $-225,898,000
Diluted EPS TTM $-2.78
Quarterly Earnings Growth YoY 97.54%

Balance Sheet

Total Cash MRQ $322,241,984
Total Cash per Share MRQ $3.63
Total Debt MRQ $
Total Debt to Equity MRQ 1220.07
Current Ratio MRQ 2.05
Book Value per Share MRQ $0.37

Cash Flow

Operating Cash Flow TTM $-160,664,000
Levered Free Cash Flow TTM $-239,234,496

TVTX Stock Info as of Jul. 5, 2025

Stock Statistics

Shares Outstanding 87,452,835
Float Shares 79,018,527
Avg 10 Volume 1,404,330
Avg 30 Volume None
Shares Short 10,329,311
Short Ratio 5.57
Short % of Shares 11.71%
% Held by Insiders 0.75%
% Held by Institutions 113.30%

Stock Price Summary

Beta 0.74
Fifty Two Week Low $7.93
Fifty Two Week High $25.29
Fifty Two Week Change 41.91%
Day 50 MA $16.87
Day 200 MA $17.91

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date